BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
Recognizing our leadership in AI, data analytics and Real-World Data.
BC Platforms in the press: Bio-IT World highlights our view on the role of AI in helping the European Health Data Space deliver secure, harmonized and high-value research.
We welcome two senior leaders: Teresa Ley as SVP of Healthcare and Partnerships for North America and EMEA, and Andrew O’Brien as SVP of Life Sciences and Healthcare Sales for JAPAC.
We welcome Keith Collier as Chief Product Officer and Michele Lichtenfield as EVP and Head of Global Marketing.
We join BRECISE, a major cancer research initiative advancing biomarker development to improve diagnosis, treatment and personalized care across Europe.
BC Platforms names Mukhtar Ahmed as CEO, strengthening our leadership with his extensive global experience across life sciences, healthcare and data-driven innovation.
BC Platforms deepens its partnership with the University of Nottingham and NUH, supporting secure data sharing and TRE-driven insights in diseases such as cancer and diabetes.
BC Platforms launches its EHDS-Ready Trusted Research Environment, enabling EU healthcare institutions to meet upcoming EHDS regulations with secure, automated and AI-driven tools.
For press and media inquiries, contact our communications team at media@bcplatforms.com.
For partnerships, business opportunities, and all other inquiries, please fill out this form